"Excellent new research in the area of Antibody Engineering. Very innovative. Excellent list of speakers. Beautifully organized meeting."
Eugene Zhukovsky, Affimed Gmbh
Do you need to meet mAb, ADC, multi format and next generation technology decision makers, influencers and end users?
If so we have a room full from large and mid cap pharma, large and SME biotech, academic and research institutes, government bodies and regulatory boards.
"Highly focussed meeting with most participants being open to sharing experiences and data"
Steve Megit, Immunocore Ltd
"Very good opportunity to meet new and existing contacts"
Tatyana Hrechdakian, Quality Assistance
"The best global antibody meeting"
Alain Beck, Centre d’Immunologie Pierre Fabre
Regulatory bodies have increased the pressure on pharmaceutical companies to measure and monitor the risk of cognitive adverse events associated with investigational treatments. At the ...
The post Conducting a clinical safety review in drug development: the regulatory environment appeared first on Total Biopharma.
White paper provided by Sciformix. Click here for more information As the number of innovator pharmaceutical and generic manufacturer partnerships grow, the lines of responsibility for meeting pharmacovigilance ...
The post Whitepaper: A successful path to fulfilling pharmacovigilance obligations appeared first on Total Biopharma.
White paper provided by Sciformix. Click here for more information 21st century technologies will create significant opportunities and challenges for all health care stakeholders. Pharmacovigilance too is ...
Innovation and strategy for pharmaceutical, biotech and R&D